CD55
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
== Function == | == Function == | ||
| - | '''CD55''' or decay-accelerating factor (DAF) serves as an inhibitor of the complement system. It is broadly expressed in malignant tumors<ref>PMID:16784816</ref>. | + | '''CD55''' or '''decay-accelerating factor''' (DAF) serves as an inhibitor of the complement system. It is broadly expressed in malignant tumors<ref>PMID:16784816</ref>. |
== Disease == | == Disease == | ||
Revision as of 11:27, 31 October 2018
| |||||||||||
3D structures of CD55
Updated on 31-October-2018
3j24 - hCD55 - human - Cryo EM
1ojv, 1ojw, 1ojy, 1ok1, 1ok2, 1ok3, 1ok9 - hCD55
1nwv - hCD55 - NMR
1uot, 1h03, 1h2p, 1h2q, 1h04 - hCD55 domains 3,4
3iyp, 2c8i, 1upn - hCD55 + echovirus - Cryo EM
5foa - hCD55 + complement C3 + complement C3B
References
- ↑ Mikesch JH, Buerger H, Simon R, Brandt B. Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies. Biochim Biophys Acta. 2006 Aug;1766(1):42-52. doi: 10.1016/j.bbcan.2006.04.001., Epub 2006 May 9. PMID:16784816 doi:http://dx.doi.org/10.1016/j.bbcan.2006.04.001
- ↑ Ozen A, Comrie WA, Ardy RC, Dominguez Conde C, Dalgic B, Beser OF, Morawski AR, Karakoc-Aydiner E, Tutar E, Baris S, Ozcay F, Serwas NK, Zhang Y, Matthews HF, Pittaluga S, Folio LR, Unlusoy Aksu A, McElwee JJ, Krolo A, Kiykim A, Baris Z, Gulsan M, Ogulur I, Snapper SB, Houwen RHJ, Leavis HL, Ertem D, Kain R, Sari S, Erkan T, Su HC, Boztug K, Lenardo MJ. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med. 2017 Jul 6;377(1):52-61. doi: 10.1056/NEJMoa1615887. Epub 2017 Jun , 28. PMID:28657829 doi:http://dx.doi.org/10.1056/NEJMoa1615887
